Recovery ⏱ Half-life: Very short. Experimental

Vilon

Vilon (KE Dipeptide)

Updated March 15, 2026

Evidence at a Glance

Regulatory statusExperimental
Khavinson Lys-Glu (KE) dipeptide immune bioregulator; not approved as a drug; Russian animal and clinical studies only
Human evidenceAnecdotal only
Animal evidenceLimited

A Lys-Glu dipeptide bioregulator with published Russian mouse lifespan/anti-tumor data and small immunology reports, but no approvals or independent human trials.

What the research does not support

  • It has no regulatory approval and is not an established immune or anti-aging medicine.
  • Mouse longevity and tumor findings come from a small number of Khavinson-affiliated studies and have not been independently reproduced.
  • There are no rigorous randomized human trials demonstrating clinical benefit.
  • It does not 'restore' the immune system or reverse thymic aging in the way vendor claims suggest.
Half-Life
Very short.
Mol. Weight
~275 g/mol

What is Vilon?

Vilon is the shortest peptide in the bioregulator series — just two amino acids — yet demonstrates targeted effects on thymic tissue and immune function.

Research Applications

Immune restoration, thymic function, T-cell support, and immunosenescence research.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard.

Half-Life & Pharmacokinetics

Very short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK, et al. “AEDG peptide regulates gene expression.” Bull Exp Biol Med. 2005

How Vilon Works

Vilon is the smallest known peptide bioregulator (dipeptide). It targets thymic tissue gene expression, supporting T-cell differentiation and immune function restoration.

Research Findings

Studied alongside Thymalin for immune reconstitution. Remarkable that a dipeptide can have targeted biological effects.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Lys-Glu
Molecular Weight ~275 g/mol
Half-Life Very short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK, et al. "AEDG peptide regulates gene expression." Bull Exp Biol Med. 2005

Related Peptides

View all →
Vosoritide
Recovery
FDA-approved modified C-type natriuretic peptide analog that promotes bone growth in children with achondroplasia.
View Profile →
ARA-290
Recovery
EPO-derived peptide that activates tissue-protective innate repair receptor without stimulating red blood cell production.
View Profile → Buy Now
Thymulin
Recovery
Zinc-dependent thymic nonapeptide essential for T-cell maturation, immune regulation, and emerging anti-aging research.
View Profile →